House GOP asks DOJ to probe Biden autopen use to ‘void’ pardons, other actions – well, that’s certainly a headline that grabs your attention. It’s like something out of a political thriller, isn’t it? The core of the matter seems to be the House Republicans’ desire to have the Department of Justice investigate whether President Biden improperly used an autopen to sign pardons and potentially other official documents. The aim, if you can believe it, is to somehow “void” these actions. It’s a bold move, to say the least.
The immediate reaction is, of course, a healthy dose of skepticism. The very idea of undoing a presidential pardon is legally dicey, to put it mildly.… Continue reading
Ghislaine Maxwell’s lawyer reported that she answered approximately 100 questions during a two-day interview with the Department of Justice regarding the Epstein case, without invoking any privileges. Maxwell’s cooperation comes as the DoJ re-examines its investigation into the case, facing scrutiny and calls for more information. Amidst this, Maxwell’s lawyer hinted at potential clemency from the president, who has the authority to do so. The former president has faced backlash for his relationship with Epstein and has tried to deflect attention away from the Epstein files, even though his name was mentioned.
Read More
UnitedHealth Group disclosed it is under Department of Justice investigations regarding its Medicare billing practices and is cooperating with the DOJ, following reports of the probes. The company has initiated a third-party review of its business policies, with an expected completion date towards the end of the third quarter. This announcement arrives after reports of potential Medicare fraud, including investigations into inflated diagnoses and pressure on doctors, prompted scrutiny of its Medicare Advantage business. Despite the ongoing investigations, UnitedHealth maintains confidence in its practices, citing independent audits that indicate their accuracy within the industry.
Read More
The Department of Justice has launched an investigation into former New York Governor Andrew Cuomo’s testimony to Congress regarding COVID-19 nursing home deaths. This follows a House panel referral alleging Cuomo lied under oath about his involvement in a state report on the issue. The investigation comes after the DOJ dropped charges against mayoral rival Eric Adams, prompting accusations of political bias. Cuomo’s spokesperson denies any wrongdoing and claims the investigation is politically motivated.
Read More
A senior Department of Justice official suggested that Jill Biden could face criminal charges for elder abuse, alleging she concealed Joe Biden’s aggressive prostate cancer diagnosis during his presidential campaign. This claim, fueled by online speculation and comments from Donald Trump Jr., centers on the assertion that Dr. Biden, despite knowing about the diagnosis, withheld this information from the public. The suggestion is largely based on conjecture and does not account for the complexities of prostate cancer detection and treatment, or Dr. Biden’s lack of medical expertise. The accusation has sparked controversy, with some questioning the timing and motives behind its surfacing.
Read More
Acting U.S. Attorney Ed Martin launched “Operation Whirlwind,” investigating alleged threats against Supreme Court justices and DOGE employees. The inquiry focuses on statements by Senator Schumer, deemed threatening by Martin, and Representative Garcia, whose comments are similarly under scrutiny. Martin’s memo, which deviates from Justice Department protocol, alleges these statements constitute threats, prompting investigations. Garcia’s office refutes the accusations, characterizing the inquiry as an attempt to silence opposition to Musk and Trump.
Read More
Special Counsel Jack Smith’s final report details Donald Trump’s alleged attempts to subvert the 2020 election, including pressuring officials to alter vote counts and incite violence on January 6th. The report concludes that sufficient evidence existed for a conviction had Trump not won the 2024 election. Trump’s actions, according to the report, involved spreading false claims of widespread voter fraud and leveraging the January 6th riot to delay election certification. Despite the evidence, the case was dropped following Trump’s reelection, with the report’s release intended to ensure public transparency.
Read More
Garland prepares to release Jack Smith’s report on the 2020 election subversion case against Trump, a development that has generated a wide spectrum of reactions, ranging from impatient anticipation to cynical skepticism. Many express frustration over the perceived delay, questioning why the release isn’t happening sooner, with some believing the report’s impact will be diminished by the timing. The protracted timeline fuels concerns about the effectiveness of the Department of Justice and leads to accusations of foot-dragging.
Garland’s perceived slow pace in releasing the report has prompted intense criticism. Some observers satirically detail the Attorney General’s imagined slow movements, emphasizing the drawn-out process and suggesting deliberate delay tactics.… Continue reading
The House Ethics Committee will release its report on former Congressman Matt Gaetz on Monday, following a bipartisan vote. The report investigates numerous allegations against Gaetz, including sexual misconduct, drug use, and campaign finance violations. Gaetz denies wrongdoing, but the report’s findings could significantly impact his political future and public perception, especially given his planned media career and potential future roles in a Trump administration. The report’s release comes after a previous DOJ investigation concluded without charges and despite prior Republican efforts to block its public disclosure.
Read More
UnitedHealth chair and executives offloaded a staggering $102 million worth of company stock just before the Department of Justice (DOJ) probe became public knowledge. This timing has understandably raised significant eyebrows, prompting questions about the nature of these transactions and the potential for insider trading. The sheer scale of the sales alone is enough to warrant a closer look.
The initial reaction suggests a strong suspicion of wrongdoing, fueled by the well-known prevalence of such practices in corporate America. The assumption that regulatory bodies, like the Securities and Exchange Commission (SEC), are unlikely to take decisive action against powerful figures only reinforces this cynicism.… Continue reading